⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT January 31, 2025

Terebyo 14 mg - Filmtabletten 14 mg (Filmtablette)

📷 Wikipedia: Teriflunomide · Source
Terebyo 14 mg - Filmtabletten 14 mg (Filmtablette)
📷 Wikipedia: Teriflunomide · Source
Terebyo 14 mg film-coated tablets are affected by this notice.
🗄
Archived (older alert)
This alert was reported 592 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
120 days in total
May 18, 2026 September 15, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Terebyo is a medicine with the active ingredient teriflunomid. It comes as small tablets in a blister pack.

What's happening? Some packs of Terebyo are hard to find right now. The 14-tablet box is not available.

Does this affect me? If you take Terebyo, you may have trouble getting your usual supply.

What should I do? Ask your pharmacist or doctor for help finding another supply or a different option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
TERIFLUNOMID
Agency-published detail

Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 28 Stück Schachtel, Blisterpackung [verfügbar, since 2025-01-31] · 14 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2025-03-27]

First published
January 31, 2025
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Terebyo 14 mg - Filmtabletten 14 mg (Filmtablette). Terebyo 14 mg film-coated tablets are affected by this notice.
▸ When was this alert issued?
This alert was issued on January 31, 2025 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.